food companies glp-1 Why makers aren't afraid of drugs GLP-1 supplements are everywhere—but do

Secondly, given the prevalence of conditions such as obesity and overweight, high blood glucose, cholesterol, and triglyceride levels, there was a need to explore alternative and potentially effective interventions beyond traditional medications. In the study, the researchers assigned 120 Lebanese participants (mean age, 17 years) with overweight or obesity to intervention groups receiving either 5 mL, 10 mL or 15 mL of ACV daily or to a control group over a 12-week period

Image Credit: zimmytws / Shutterstock In a recent study published in JAMA Network Open , researchers investigated the associations between glucagon-like peptide 1 receptor agonists (GLP-1RAs) and all-cause mortality and recurrence-free survival (RFS) among adult female breast cancer (BC) patients

The tenor of these stories surprised me

Specifically, it separates the components of a sample and measures the concentration of each